Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
Fisk University MARC U*STAR Program
Training in International Maternal and Child Health
Structural and Phylogenetic Studies of the Homeodomain Protein Family
Biomedical Research Support
Recently added grants:
Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction
A role for immune cell plasticity in commensal survival and escalation of inflammation
Redox Regulation of Gingival Inflammation
Trade-offs in human observer performance, image quality metrics, and patient dose
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant
